Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China
· Delayed Price · Currency is CNY 15.64
-0.09 (-0.57%)
Apr 29, 2026, 3:04 PM CST
SHE:300233 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 66.93 | 44.19 | 196.78 | 174.71 | 273.37 | 107.98 | Upgrade
|
| Depreciation & Amortization | 321.52 | 321.52 | 319.26 | 308.17 | 255.77 | 224.03 | Upgrade
|
| Other Amortization | 3.16 | 3.16 | 3.51 | 3.49 | 3.01 | 9.46 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.95 | -2.95 | -1.45 | 2.16 | -1.53 | -1.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 23.86 | 23.86 | 14.53 | 2.49 | 21.32 | 39.07 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.79 | -2.79 | 1.67 | -0.59 | 8.68 | -12.5 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.39 | 0.39 | -2.49 | 2.77 | -0.08 | -4.52 | Upgrade
|
| Other Operating Activities | 112.16 | 38.83 | 42.48 | 88.03 | 50.91 | 78.41 | Upgrade
|
| Change in Accounts Receivable | 58.17 | 58.17 | -28.11 | -124.9 | -314.2 | -89.1 | Upgrade
|
| Change in Inventory | 101.37 | 101.37 | -115.59 | 32.08 | -202.78 | -133.37 | Upgrade
|
| Change in Accounts Payable | -263.48 | -263.48 | -137.11 | 213.55 | 127.52 | 194.72 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | -16.46 | 21.35 | - | Upgrade
|
| Operating Cash Flow | 415.71 | 319.64 | 296.59 | 664.08 | 255.63 | 437.19 | Upgrade
|
| Operating Cash Flow Growth | 68.54% | 7.77% | -55.34% | 159.78% | -41.53% | -19.95% | Upgrade
|
| Capital Expenditures | -111.44 | -100.88 | -142.61 | -342.9 | -373.67 | -376.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 51.51 | 23.79 | 62.29 | 24.86 | 6.48 | 5.67 | Upgrade
|
| Divestitures | - | - | - | - | -0.96 | - | Upgrade
|
| Investment in Securities | -68.34 | -68.34 | -4 | 10 | 3.9 | 129.1 | Upgrade
|
| Other Investing Activities | -109.93 | -10.52 | 0.01 | -1.95 | 6.42 | 9.84 | Upgrade
|
| Investing Cash Flow | -238.19 | -155.96 | -84.32 | -309.99 | -357.82 | -231.54 | Upgrade
|
| Long-Term Debt Issued | - | 137.98 | 239 | 348.37 | 475.97 | 383.7 | Upgrade
|
| Long-Term Debt Repaid | - | -274.17 | -283.38 | -449.03 | -418.99 | -390.7 | Upgrade
|
| Net Debt Issued (Repaid) | -174.42 | -136.19 | -44.38 | -100.66 | 56.98 | -7 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 56.94 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -55.01 | - | - | -80.01 | Upgrade
|
| Common Dividends Paid | -104.24 | -162.51 | -131.67 | -83.52 | -104.78 | -105.19 | Upgrade
|
| Other Financing Activities | 0.37 | - | -12.71 | -59.13 | -5.31 | 0.54 | Upgrade
|
| Financing Cash Flow | -278.29 | -298.7 | -243.77 | -243.31 | 3.83 | -191.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.48 | 1.84 | 5.96 | 3.47 | 4.3 | -4.97 | Upgrade
|
| Net Cash Flow | -101.26 | -133.17 | -25.54 | 114.24 | -94.07 | 9.01 | Upgrade
|
| Free Cash Flow | 304.27 | 218.76 | 153.97 | 321.18 | -118.04 | 61.04 | Upgrade
|
| Free Cash Flow Growth | 125.92% | 42.08% | -52.06% | - | - | -77.70% | Upgrade
|
| Free Cash Flow Margin | 11.00% | 7.99% | 4.56% | 9.08% | -3.37% | 1.94% | Upgrade
|
| Free Cash Flow Per Share | 0.83 | 0.59 | 0.41 | 0.83 | -0.31 | 0.16 | Upgrade
|
| Cash Income Tax Paid | 201.86 | 195.64 | 172.91 | 155.47 | 114.1 | 151.12 | Upgrade
|
| Levered Free Cash Flow | 367.94 | 278.77 | 16.57 | 251.22 | 115.33 | 9.67 | Upgrade
|
| Unlevered Free Cash Flow | 374.7 | 285.53 | 28.12 | 266.8 | 132.09 | 26.57 | Upgrade
|
| Change in Working Capital | -106.57 | -106.57 | -277.69 | 82.85 | -355.82 | -3.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.